(Source: Sariel Diagnostics.)
  • Datametrex AI (TSXV:DM) has completed its acquisition of mobile game “Cereal Crunch” from Sariel Diagnostics in a C$3.5 million deal
  • The game, along with its assets including software, will be acquired by issuing 70 million common shares of Datametrex, each valued at $0.05
  • Launched on April 2, the Crunch Token is integral to the “Cereal Crunch” game ecosystem, supporting its play-to-earn blockchain gaming model
  • Datametrex stock last traded at $0.015 per share

Datametrex AI (TSXV:DM) has completed its acquisition of mobile game “Cereal Crunch” from Sariel Diagnostics in a C$3.5 million deal.

The game, along with its assets including software, intellectual property, roughly C$150,000 in cash, user databases and the Crunch Token will be acquired by issuing 70 million common shares of Datametrex, each valued at $0.05.

Launched on April 2, the Crunch Token is integral to the “Cereal Crunch” game ecosystem, supporting its play-to-earn blockchain gaming model.

The deal also involves a C$300,000 cash payment and Sariel’s Coinsquare account, which is essential for handling game-related cryptocurrency transactions.

“Cereal Crunch” aims to deliver a unique gaming experience by combining entertainment with the opportunity for crypto earnings, utilizing its “match-three” mechanics and cryptocurrency rewards system.

“The acquisition of Cereal Crunch aligns perfectly with our strategic focus on innovative technologies,” Datametrex President Charles Park said in a news release. “We are excited to bring ‘Cereal Crunch’ into our portfolio, offering immense potential for growth and success in this emerging sectors of e-gaming and blockchain.”

“This acquisition signifies a major milestone for Sariel, validating our hard work on ‘Cereal Crunch,’” John Karagiannidis, president of Sariel Diagnostics Corp., added. “Datametrex is the ideal partner to lead the game’s development to new heights.”

Datametrex develops innovative solutions across technology, artificial intelligence and healthcare to enhance operational efficiencies and business outcomes.

Datametrex AI Ltd. stock (TSXV:DM) last traded at $0.015 per share and has fallen by 78.57 per cent year-over-year, and by 57.14 per cent since 2019.

Join the discussion: Find out what everybody’s saying about this potentially undervalued microcap stock on the Datametrex AI Ltd. Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top photo: Sariel Diagnostics.)


More From The Market Online
Canadian flag, medical equipment and stock chart

The top 10 Canadian medical stocks

The Canadian medical industry powers numerous high-potential stocks whose products and services lie at the foundation of human life.
Quantum computer

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal

Cybersecurity stock Quantum eMotion (TSXV:QNC) takes a major step in the go-to-market strategy for its Sentry-Q platform.
An AI generated photo of a stethoscope on a computerized setting

How one company is disrupting PoC testing

When it comes to Gemina Laboratories Ltd. (CSE:GLAB), the Canada and U.K.-based company is progressing a range of PoC diagnostic technologies.
AI generated stock image

Investing in Canadian medical stocks under $10

Healthcare stocks in Canada are publicly traded companies that operate in various sectors of the healthcare industry.